High mobility group box 1 (HMGB1) is one of the ligands of TLR4 and RAGE, and its interaction can exert pro-inflammatory effects, which means that HMGB1 is an important target for therapeutic strategies in DN. This evidence concerns the gene HMGB1 and liver dysplastic nodule.